Simplex Trading’s CASI Pharmaceuticals CASI Stock Holding History

Simplex Trading’s Portfolio CASI Stock Details CASI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-228	Closed	-$25	–	9346
2026 Q1	$25	Buy	228 +95	+71%	+$86	﹤0.01%	8918
2025 Q4	$113	Sell	133 -12	-8%	-$16	﹤0.01%	8303
2025 Q3	$0	Buy	145 +119	+458%	+$212	﹤0.01%	9118
2025 Q2	$0	Sell	26 -88	-77%	-$161	﹤0.01%	8704
2025 Q1	$0	Buy	+114	New	+$279	﹤0.01%	8595
2024 Q3	–	Sell	-1,042	Closed	-$5K	–	8556
2024 Q2	$5K	Buy	1,042 +419	+67%	+$1.3K	﹤0.01%	7833
2024 Q1	$2K	Buy	623 +570	+1,075%	+$3.07K	﹤0.01%	8368
2023 Q4	$0	Buy	+53	New	+$255	﹤0.01%	8843

Other funds holding CASI

WPA

West Paces Advisors Atlanta, Georgia $596M AUM 22.29% 1-Year Est. Return

Simplex Trading's CASI Position: Q2 2026 in Review

Simplex Trading sold out of CASI Pharmaceuticals (CASI) in Q2 2026, closing a stake of 228 shares — an estimated $25 sold.

Simplex Trading first reported a position in CASI in Q4 2023 and held it in 8 quarters. The position peaked at $5K in Q2 2024. 1 fund tracked by Wall St. Rank holds CASI as of Q2 2026.

Simplex Trading reported no remaining CASI Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Simplex Trading sold 228 CASI Pharmaceuticals shares in Q2 2026, an estimated $25.
Simplex Trading first reported a position in CASI Pharmaceuticals in Q4 2023 and held it in 8 quarters.
Simplex Trading's CASI Pharmaceuticals position peaked at $5K in Q2 2024.
1 fund tracked by Wall St. Rank held CASI Pharmaceuticals as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.